Literature DB >> 7889184

Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories.

A M Andersson1, H Orskov, M B Ranke, S Shalet, N E Skakkebaek.   

Abstract

To compare interpretations of growth hormone (GH) provocative tests in laboratories using six different GH immunoassays (one enzymeimmunometric assay (EIMA, assay 1), one immunoradiometric assay (IRMA, assay 5), one time-resolved fluorimmunometric assay (TRFIA, assay 3) and three radioimmunoassays (RIAs, assays 2, 4 and 6)), aliquots of peak samples from GH provocative tests were distributed between the four participating laboratories, quantified in the respective immunoassays and interpreted according to the cut-off values for provocative tests defined for each assay method. There was a high degree of relative correlation between the different assays, but absolute GH estimates differed. Assays 2, 4, 5 and 6 yielded almost identical GH levels. Assays 1 and 3 yielded serum GH levels approximately 39% and 70%, respectively, of those of assays 2, 4, 5 and 6. Although the absolute GH level measured in the various assay methods varied, there was good agreement between the interpretation of a given sample among the participating laboratories. This indicates that the differences in estimates of serum GH concentration by different immunoassay systems can be compensated for when cut-off values are defined for each method.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7889184     DOI: 10.1530/eje.0.1320340

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  2 in total

1.  Early retesting by GHRH + arginine test shows normal GH response in most children with idiopathic GH deficiency.

Authors:  C Bizzarri; S Pedicelli; B Boscherini; G Bedogni; M Cappa; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2014-11-07       Impact factor: 4.256

Review 2.  Growth hormone variants: a potential avenue for a better diagnostic characterization of growth hormone deficiency in children.

Authors:  A E Rigamonti; M Bozzola; G Banfi; C Meazza; E E Müller; S G Cella
Journal:  J Endocrinol Invest       Date:  2012-10-01       Impact factor: 5.467

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.